1.
Waddington C. The Strategy of the Genes. George Allen & Unwin; 1957.
2.
Campbell KH, McWhir J, Ritchie WA, Wilmut I. Sheep cloned by nuclear transfer
from a cultured cell line. Nature. 1996;380(6569):64-66.
3.
Wilmut I, Schnieke AE, McWhir J, Kind AJ, Campbell KH. Viable offspring derived
from fetal and adult mammalian cells. Nature. 1997;385(6619):810-813.
4.
Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic
and adult fibroblast cultures by defined factors. Cell. 2006;126(4):663-676.
5.
Aoi T, Yae K, Nakagawa M, Ichisaka T, Okita K, Takahashi K, Chiba T, Yamanaka S.
Generation of pluripotent stem cells from adult mouse liver and stomach cells.
Science. 2008;321(5889):699-702.
6.
Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, Tomoda K, Yamanaka S.
Induction of pluripotent stem cells from adult human fibroblasts by defined factors.
Cell. 2007;131(5):861-872.
7.
Zhou Q, Brown J, Kanarek A, Rajagopal J, Melton DA. In vivo reprogramming of
adult pancreatic exocrine cells to beta-cells. Nature. 2008;455(7213):627-632.
8.
Cobaleda C, Jochum W, Busslinger M. Conversion of mature B cells into T cells by
dedifferentiation to uncommitted progenitors. Nature. 2007;449(7161):473-477.
9.
Vierbuchen T, Ostermeier A, Pang ZP, Kokubu Y, Südhof TC, Wernig M. Direct
conversion of fibroblasts to functional neurons by defined factors. Nature.
2010;463(7284):1035-1041.
10.
Ieda M, Fu JD, Delgado-Olguin P, Vedantham V, Hayashi Y, Bruneau BG, Srivastava
D. Direct reprogramming of fibroblasts into functional cardiomyocytes by defined
factors. Cell. 2010;142(3):375-386.
11.
Szabo E, Rampalli S, Risueño RM, Schnerch A, Mitchell R, Fiebig-Comyn A,
Levadoux-Martin M, Bhatia M. Direct conversion of human fibroblasts to
multilineage blood progenitors. Nature. 2010;468(7323):521-526.
12.
Cates K, McCoy MJ, Kwon JS, Liu Y, Abernathy DG, Zhang B, Liu S, Gontarz P, Kim
64
WK, Chen S, Kong W, Ho JN, Burbach KF, Gabel HW, Morris SA, Yoo AS.
Deconstructing Stepwise Fate Conversion of Human Fibroblasts to Neurons by
MicroRNAs. Cell Stem Cell. 2020.
13.
Zhang M, Dong Y, Hu F, Yang D, Zhao Q, Lv C, Wang Y, Xia C, Weng Q, Liu X, Li C,
Zhou P, Wang T, Guan Y, Guo R, Liu L, Geng Y, Wu H, Du J, Hu Z, Xu S, Chen J, He
A, Liu B, Wang D, Yang YG, Wang J. Transcription factor Hoxb5 reprograms B cells
into functional T lymphocytes. Nat Immunol. 2018;19(3):279-290.
14.
Thomas ED, Buckner CD, Banaji M, Clift RA, Fefer A, Flournoy N, Goodell BW,
Hickman RO, Lerner KG, Neiman PE, Sale GE, Sanders JE, Singer J, Stevens M,
Storb R, Weiden PL. One hundred patients with acute leukemia treated by
chemotherapy, total body irradiation, and allogeneic marrow transplantation. Blood.
1977;49(4):511-533.
15.
Kanda Y, Kanda J, Atsuta Y, Maeda Y, Ichinohe T, Ohashi K, Fukuda T, Miyamura
K, Iida H, Mori T, Iwato K, Eto T, Kawa K, Morita S, Morishima Y. Impact of a single
human leucocyte antigen (HLA) allele mismatch on the outcome of unrelated bone
marrow transplantation over two time periods. A retrospective analysis of 3003
patients from the HLA Working Group of the Japan Society for Blood and Marrow
Transplantation. Br J Haematol. 2013;161(4):566-577.
16.
Helgason CD, Sauvageau G, Lawrence HJ, Largman C, Humphries RK.
Overexpression of HOXB4 enhances the hematopoietic potential of embryonic stem
cells differentiated in vitro. Blood. 1996;87(7):2740-2749.
17.
Kyba M, Perlingeiro RC, Daley GQ. HoxB4 confers definitive lymphoid-myeloid
engraftment potential on embryonic stem cell and yolk sac hematopoietic progenitors.
Cell. 2002;109(1):29-37.
18.
Matsumoto K, Isagawa T, Nishimura T, Ogaeri T, Eto K, Miyazaki S, Miyazaki J,
Aburatani H, Nakauchi H, Ema H. Stepwise development of hematopoietic stem cells
from embryonic stem cells. PLoS One. 2009;4(3):e4820.
19.
Lis R, Karrasch CC, Poulos MG, Kunar B, Redmond D, Duran JGB, Badwe CR,
Schachterle W, Ginsberg M, Xiang J, Tabrizi AR, Shido K, Rosenwaks Z, Elemento O,
Speck NA, Butler JM, Scandura JM, Rafii S. Conversion of adult endothelium to
immunocompetent haematopoietic stem cells. Nature. 2017;545(7655):439-445.
65
20.
Rowe RG, Mandelbaum J, Zon LI, Daley GQ. Engineering Hematopoietic Stem Cells:
Lessons from Development. Cell Stem Cell. 2016;18(6):707-720.
21.
Suzuki N, Yamazaki S, Yamaguchi T, Okabe M, Masaki H, Takaki S, Otsu M,
Nakauchi H. Generation of engraftable hematopoietic stem cells from induced
pluripotent stem cells by way of teratoma formation. Mol Ther. 2013;21(7):1424-1431.
22.
Tsukada M, Ota Y, Wilkinson AC, Becker HJ, Osato M, Nakauchi H, Yamazaki S.
In Vivo Generation of Engraftable Murine Hematopoietic Stem Cells by Gfi1b, c-Fos,
and Gata2 Overexpression within Teratoma. Stem Cell Reports. 2017;9(4):1024-1033.
23.
Elcheva I, Brok-Volchanskaya V, Kumar A, Liu P, Lee JH, Tong L, Vodyanik M,
Swanson S, Stewart R, Kyba M, Yakubov E, Cooke J, Thomson JA, Slukvin I. Direct
induction of haematoendothelial programs in human pluripotent stem cells by
transcriptional regulators. Nat Commun. 2014;5:4372.
24.
Doulatov S, Vo LT, Chou SS, Kim PG, Arora N, Li H, Hadland BK, Bernstein ID,
Collins JJ, Zon LI, Daley GQ. Induction of multipotential hematopoietic progenitors
from human pluripotent stem cells via respecification of lineage-restricted precursors.
Cell Stem Cell. 2013;13(4):459-470.
25.
Sugimura R, Jha DK, Han A, Soria-Valles C, da Rocha EL, Lu Y-F, Goettel JA, Serrao
E, Rowe RG, Malleshaiah M, Wong I, Sousa P, Zhu TN, Ditadi A, Keller G, Engelman
AN, Snapper SB, Doulatov S, Daley GQ. Haematopoietic stem and progenitor cells
from human pluripotent stem cells. Nature. 2017;545(7655):432-438.
26.
Ieyasu A, Ishida R, Kimura T, Morita M, Wilkinson AC, Sudo K, Nishimura T,
Ohehara J, Tajima Y, Lai CY, Otsu M, Nakamura Y, Ema H, Nakauchi H, Yamazaki
S. An All-Recombinant Protein-Based Culture System Specifically Identifies
Hematopoietic Stem Cell Maintenance Factors. Stem Cell Reports. 2017;8(3):500-508.
27.
Wilkinson AC, Ishida R, Kikuchi M, Sudo K, Morita M, Crisostomo RV, Yamamoto R,
Loh KM, Nakamura Y, Watanabe M, Nakauchi H, Yamazaki S. Long-term ex vivo
haematopoietic-stem-cell expansion allows nonconditioned transplantation. Nature.
2019;571(7763):117-121.
28.
Eminli S, Foudi A, Stadtfeld M, Maherali N, Ahfeldt T, Mostoslavsky G, Hock H,
Hochedlinger K. Differentiation stage determines potential of hematopoietic cells for
reprogramming into induced pluripotent stem cells. Nat Genet. 2009;41(9):968-976.
66
29.
Wang Y, Yates F, Naveiras O, Ernst P, Daley GQ. Embryonic stem cell-derived
hematopoietic stem cells. Proc Natl Acad Sci U S A. 2005;102(52):19081-19086.
30.
Riddell J, Gazit R, Garrison BS, Guo G, Saadatpour A, Mandal PK, Ebina W,
Volchkov P, Yuan GC, Orkin SH, Rossi DJ. Reprogramming committed murine blood
cells to induced hematopoietic stem cells with defined factors. Cell. 2014;157(3):549564.
31.
Okabe M, Otsu M, Ahn DH, Kobayashi T, Morita Y, Wakiyama Y, Onodera M, Eto K,
Ema H, Nakauchi H. Definitive proof for direct reprogramming of hematopoietic cells
to pluripotency. Blood. 2009;114(9):1764-1767.
32.
Deneault E, Cellot S, Faubert A, Laverdure JP, Fréchette M, Chagraoui J, Mayotte
N, Sauvageau M, Ting SB, Sauvageau G. A functional screen to identify novel
effectors of hematopoietic stem cell activity. Cell. 2009;137(2):369-379.
33.
Sauvageau G, Thorsteinsdottir U, Eaves CJ, Lawrence HJ, Largman C, Lansdorp
PM, Humphries RK. Overexpression of HOXB4 in hematopoietic cells causes the
selective expansion of more primitive populations in vitro and in vivo. Genes Dev.
1995;9(14):1753-1765.
34.
Hamanaka S, Nabekura T, Otsu M, Yoshida H, Nagata M, Usui J, Takahashi S,
Nagasawa T, Nakauchi H, Onodera M. Stable transgene expression in mice generated
from retrovirally transduced embryonic stem cells. Mol Ther. 2007;15(3):560-565.
35.
Nabekura T, Otsu M, Nagasawa T, Nakauchi H, Onodera M. Potent vaccine therapy
with dendritic cells genetically modified by the gene-silencing-resistant retroviral
vector GCDNsap. Mol Ther. 2006;13(2):301-309.
36.
Sanuki S, Hamanaka S, Kaneko S, Otsu M, Karasawa S, Miyawaki A, Nakauchi H,
Nagasawa T, Onodera M. A new red fluorescent protein that allows efficient marking
of murine hematopoietic stem cells. J Gene Med. 2008;10(9):965-971.
37.
Osawa M, Hanada K, Hamada H, Nakauchi H. Long-term lymphohematopoietic
reconstitution by a single CD34-low/negative hematopoietic stem cell. Science.
1996;273(5272):242-245.
38.
Sung LY, Gao S, Shen H, Yu H, Song Y, Smith SL, Chang CC, Inoue K, Kuo L, Lian
J, Li A, Tian XC, Tuck DP, Weissman SM, Yang X, Cheng T. Differentiated cells are
67
more efficient than adult stem cells for cloning by somatic cell nuclear transfer. Nat
Genet. 2006;38(11):1323-1328.
39.
Noda S, Horiguchi K, Ichikawa H, Miyoshi H. Repopulating activity of ex vivoexpanded murine hematopoietic stem cells resides in the CD48-c-Kit+Sca-1+lineage
marker- cell population. Stem Cells. 2008;26(3):646-655.
40.
Thorsteinsdottir U, Mamo A, Kroon E, Jerome L, Bijl J, Lawrence HJ, Humphries K,
Sauvageau G. Overexpression of the myeloid leukemia-associated Hoxa9 gene in
bone marrow cells induces stem cell expansion. Blood. 2002;99(1):121-129.
41.
Bach C, Buhl S, Mueller D, García-Cuéllar MP, Maethner E, Slany RK.
Leukemogenic transformation by HOXA cluster genes. Blood. 2010;115(14):29102918.
42.
Kroon E, Krosl J, Thorsteinsdottir U, Baban S, Buchberg AM, Sauvageau G. Hoxa9
transforms primary bone marrow cells through specific collaboration with Meis1a but
not Pbx1b. Embo j. 1998;17(13):3714-3725.
43.
Cellot S, Krosl J, Chagraoui J, Meloche S, Humphries RK, Sauvageau G. Sustained
in vitro trigger of self-renewal divisions in Hoxb4hiPbx1(10) hematopoietic stem cells.
Exp Hematol. 2007;35(5):802-816.
44.
Seita J, Sahoo D, Rossi DJ, Bhattacharya D, Serwold T, Inlay MA, Ehrlich LI,
Fathman JW, Dill DL, Weissman IL. Gene Expression Commons: an open platform
for absolute gene expression profiling. PLoS One. 2012;7(7):e40321.
45.
Zon LI. Intrinsic and extrinsic control of haematopoietic stem-cell self-renewal.
Nature. 2008;453(7193):306-313.
46.
Nakahara F, Sakata-Yanagimoto M, Komeno Y, Kato N, Uchida T, Haraguchi K,
Kumano K, Harada Y, Harada H, Kitaura J, Ogawa S, Kurokawa M, Kitamura T,
Chiba S. Hes1 immortalizes committed progenitors and plays a role in blast crisis
transition in chronic myelogenous leukemia. Blood. 2010;115(14):2872-2881.
47.
Izawa K, Yamazaki S, Becker HJ, Bhadury J, Kakegawa T, Sakaguchi M, Tojo A.
Activated HoxB4-induced hematopoietic stem cells from murine pluripotent stem
cells via long-term programming. Experimental Hematology. 2020;89:68-79.e67.
48.
Schiedlmeier B, Klump H, Will E, Arman-Kalcek G, Li Z, Wang Z, Rimek A, Friel J,
68
Baum C, Ostertag W. High-level ectopic HOXB4 expression confers a profound in vivo
competitive growth advantage on human cord blood CD34+ cells, but impairs
lymphomyeloid differentiation. Blood. 2003;101(5):1759-1768.
49.
Lee GS, Kim BS, Sheih JH, Moore M. Forced expression of HoxB4 enhances
hematopoietic differentiation by human embryonic stem cells. Mol Cells.
2008;25(4):487-493.
50.
Bowles KM, Vallier L, Smith JR, Alexander MR, Pedersen RA. HOXB4
overexpression promotes hematopoietic development by human embryonic stem cells.
Stem Cells. 2006;24(5):1359-1369.
51.
Pilat S, Carotta S, Schiedlmeier B, Kamino K, Mairhofer A, Will E, Modlich U,
Steinlein P, Ostertag W, Baum C, Beug H, Klump H. HOXB4 enforces equivalent
fates of ES-cell-derived and adult hematopoietic cells. Proc Natl Acad Sci U S A.
2005;102(34):12101-12106.
52.
Akala OO, Park IK, Qian D, Pihalja M, Becker MW, Clarke MF. Long-term
haematopoietic
reconstitution
by
Trp53-/-p16Ink4a-/-p19Arf-/-
multipotent
progenitors. Nature. 2008;453(7192):228-232.
53.
He S, Kim I, Lim MS, Morrison SJ. Sox17 expression confers self-renewal potential
and fetal stem cell characteristics upon adult hematopoietic progenitors. Genes Dev.
2011;25(15):1613-1627.
54.
Oshima M, Endoh M, Endo TA, Toyoda T, Nakajima-Takagi Y, Sugiyama F, Koseki H,
Kyba M, Iwama A, Osawa M. Genome-wide analysis of target genes regulated by
HoxB4 in hematopoietic stem and progenitor cells developing from embryonic stem
cells. Blood. 2011;117(15):e142-e150.
55.
Schiedlmeier B, Santos AC, Ribeiro A, Moncaut N, Lesinski D, Auer H, Kornacker K,
Ostertag W, Baum C, Mallo M, Klump H. HOXB4's road map to stem cell expansion.
Proc Natl Acad Sci U S A. 2007;104(43):16952-16957.
56.
Forrester LM, Jackson M. Mechanism of action of HOXB4 on the hematopoietic
differentiation of embryonic stem cells. Stem Cells. 2012;30(3):379-385.
57.
Kirito K, Fox N, Kaushansky K. Thrombopoietin stimulates Hoxb4 expression: an
explanation for the favorable effects of TPO on hematopoietic stem cells. Blood.
69
2003;102(9):3172-3178.
58.
Velardi E, Tsai JJ, Radtke S, Cooper K, Argyropoulos KV, Jae-Hung S, Young LF,
Lazrak A, Smith OM, Lieberman S, Kreines F, Shono Y, Wertheimer T, Jenq RR,
Hanash AM, Narayan P, Lei Z, Moore MA, Kiem HP, van den Brink MRM, Dudakov
JA. Suppression of luteinizing hormone enhances HSC recovery after hematopoietic
injury. Nat Med. 2018;24(2):239-246.
59.
Li S, Ali S, Duan X, Liu S, Du J, Liu C, Dai H, Zhou M, Zhou L, Yang L, Chu P, Li L,
Bhatia R, Schones DE, Wu X, Xu H, Hua Y, Guo Z, Yang Y, Zheng L, Shen B. JMJD1B
Demethylates H4R3me2s and H3K9me2 to Facilitate Gene Expression for
Development of Hematopoietic Stem and Progenitor Cells. Cell Rep. 2018;23(2):389403.
60.
Konuma T, Nakamura S, Miyagi S, Negishi M, Chiba T, Oguro H, Yuan J, MochizukiKashio M, Ichikawa H, Miyoshi H, Vidal M, Iwama A. Forced expression of the
histone demethylase Fbxl10 maintains self-renewing hematopoietic stem cells. Exp
Hematol. 2011;39(6):697-709.e695.
61.
Nishizawa M, Chonabayashi K, Nomura M, Tanaka A, Nakamura M, Inagaki A,
Nishikawa M, Takei I, Oishi A, Tanabe K, Ohnuki M, Yokota H, Koyanagi-Aoi M,
Okita K, Watanabe A, Takaori-Kondo A, Yamanaka S, Yoshida Y. Epigenetic
Variation between Human Induced Pluripotent Stem Cell Lines Is an Indicator of
Differentiation Capacity. Cell Stem Cell. 2016;19(3):341-354.
62.
Wada T, Kikuchi J, Nishimura N, Shimizu R, Kitamura T, Furukawa Y. Expression
levels of histone deacetylases determine the cell fate of hematopoietic progenitors. J
Biol Chem. 2009;284(44):30673-30683.
63.
Zhang XB, Beard BC, Trobridge GD, Wood BL, Sale GE, Sud R, Humphries RK, Kiem
HP. High incidence of leukemia in large animals after stem cell gene therapy with a
HOXB4-expressing retroviral vector. J Clin Invest. 2008;118(4):1502-1510.
64.
Krosl J, Austin P, Beslu N, Kroon E, Humphries RK, Sauvageau G. In vitro expansion
of hematopoietic stem cells by recombinant TAT-HOXB4 protein. Nat Med.
2003;9(11):1428-1432.
65.
Amsellem S, Pflumio F, Bardinet D, Izac B, Charneau P, Romeo PH, DubartKupperschmitt A, Fichelson S. Ex vivo expansion of human hematopoietic stem cells
70
by direct delivery of the HOXB4 homeoprotein. Nat Med. 2003;9(11):1423-1427.
71
8. 謝辞
本稿の作製にあたり、研究の機会を与えてくださりご指導ご鞭撻を賜りまし
た、東京大学医科学研究所附属病院
先端医療研究センター
分野
東條有伸前教授に心より御礼を申し上げ
南谷泰仁教授、分子療法分野
造血病態制御学
ます。また、研究を進めるにあたり、親身なご指導ならびにご助言を賜りました
東京大学医科学研究所
中内啓光東京大学特任教授に深く感謝を申し上げます。
また研究の遂行にあたりご協力いただいた北里大学医学部輸血部
大津真博士
に深く感謝申し上げます。
ウイルスベクターの作製や評価システムの構築に多大なる助言をしていただ
いた京都大学高等研究院
山本玲博士、フローサイトメトリー解析でご支援い
ただいた東京大学医科学研究所幹細胞治療研究センターの山崎裕治氏に深く感
謝申し上げます。研究生活全般にわたりご協力およびご支援いただきました津
久井弘子氏、岡田京子氏に深く感謝申し上げます。
最後に、研究の継続を支持し心身ともに支えてくれた妻子および両親に心か
らの謝意を記します。
72
...
論文の公開元へ
